These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Comparison of three schedules of intravesical epirubicin in patients with non-muscle-invasive bladder cancer. Hendricksen K; Witjes WP; Idema JG; Kums JJ; van Vierssen Trip OB; de Bruin MJ; Vergunst H; Caris CT; Janzing-Pastors MH; Witjes JA Eur Urol; 2008 May; 53(5):984-91. PubMed ID: 18248876 [TBL] [Abstract][Full Text] [Related]
45. Use of mitomycin as prophylaxis following endoscopic resection of superficial bladder cancer. Huland H; Otto U Urology; 1985 Oct; 26(4 Suppl):32-5. PubMed ID: 4049627 [TBL] [Abstract][Full Text] [Related]
46. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial. Divrik RT; Yildirim U; Zorlu F; Ozen H J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720 [TBL] [Abstract][Full Text] [Related]
50. [Lymphatic system changes after the endolymphatic administration of an oil-based solution of dibunol]. Anan'ev VG; Kapuller LL; Eropkin PV; Shiiataia OK Vopr Onkol; 1984; 30(5):63-7. PubMed ID: 6328761 [TBL] [Abstract][Full Text] [Related]
51. [The use of Dibunol in the treatment of the oral mucosa and periodontium]. Groshikov MI; Patrikeev VK; Pozharitskaia MM; Disvetova VV; Aref'eva SA; Gerasina OV Stomatologiia (Mosk); 1974; 53(2):15-7. PubMed ID: 4528930 [No Abstract] [Full Text] [Related]
52. [1st attempt at using the antioxidant dibunol in the acute stage of a myocardial infarct]. Golikov AP; Polumiskov VIu; Berestov AA; Riabinin VA Kardiologiia; 1984 Jan; 24(1):15-8. PubMed ID: 6700125 [TBL] [Abstract][Full Text] [Related]
53. [Use of dibunol phonophoresis in treating the initial stage of periodontosis]. Nikitina TV; Dedeian SA; Mikhaĭlova RI; Zheltova SI Stomatologiia (Mosk); 1982; 61(1):25-6. PubMed ID: 6977893 [No Abstract] [Full Text] [Related]
54. [In vitro sensitivity of bladder cancer cells (T24) to various anticancer drugs and intravesical use of a selected drug (author's transl)]. Kato T; Kumagai I; Miura K; Nemoto R; Nishimoto T Nihon Hinyokika Gakkai Zasshi; 1978 Oct; 69(10):1308-13. PubMed ID: 732065 [No Abstract] [Full Text] [Related]
55. Antineoplaston A in cancer therapy. (I). Burzynski SR; Stolzmann Z; Szopa B; Stolzmann E; Kaltenberg OP Physiol Chem Phys; 1977; 9(6):485-500. PubMed ID: 275868 [TBL] [Abstract][Full Text] [Related]
56. [The prevention of surgical stress in lung cancer patients with the antioxidant dibunol]. Baraboĭ VA; Bororov LV; Hunina LM; Maievs'ka LP Lik Sprava; 1994; (7-8):143-5. PubMed ID: 7900341 [TBL] [Abstract][Full Text] [Related]
57. [Treatment with a new preparation using peplomycin emulsion in hydroxypropylcellulosum. Analysis of immediate response in sixty-two patients with bladder cancer]. Yasumoto R; Asakawa M; Iseki T; Nakatani T; Kishimoto T; Maekawa M; Umeda M; Senju M; Horii A; Kawamura M Nihon Hinyokika Gakkai Zasshi; 1989 Dec; 80(12):1728-32. PubMed ID: 2483184 [TBL] [Abstract][Full Text] [Related]
59. Treatment of neoplasia of the bladder with topical application of a synthetic peptide complex preparation: preliminary results. Battelli T; Bonsignori M; Lombardi R; Manocchi P; Perilli A Curr Med Res Opin; 1976; 4(3):189-1. PubMed ID: 949898 [TBL] [Abstract][Full Text] [Related]
60. [Local and general clinical effect of estriol in patients with anomalies in the position of the genitalia]. Cherevishnik ZhV Akush Ginekol (Mosk); 1978 Oct; (10):44-8. PubMed ID: 362969 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]